Results 131 to 140 of about 12,511,207 (306)
Developer and Partnership Differences in COVID-19 and Other Infections: Insights from DNA Vaccines
Historically, vaccine development has been heavily supported by government and public institutions. On the other hand, private biopharmaceutical companies have played a significant role in the development of innovative new therapies using novel ...
Ryo Okuyama
doaj +1 more source
Political drivers of and barriers to Public-Private Partnerships: The role of political involvement [PDF]
The application and design of public-private partnerships between the extremes of purely public or purely private task fulfilment in public services is, in practice, subject to political processes.
Gawel, Erik
core
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola +5 more
wiley +1 more source
The classification of forms of public-private partnership: synthesis foreign and domestic experience
The content of the term «public-private partnership» is updated. The main causes of the needs identified in the public-private partnership. The scope of application of public-private partnership in Ukraine are determined.
Yuliya Zaloznova +2 more
doaj
Aim The shortage of trained clinical assessors in African National Regulatory Authorities (NRAs) poses a challenge to effective regulatory decision‐making. Developed in line with the World Health Organization's (WHO) Global Competency Framework (WHO‐GCF), a university‐certified short course, Dossier assessment for clinical assessors in Africa, was ...
Stephanie Leigh +19 more
wiley +1 more source
Capacity building in medicines development and regulation in Africa—Overview on recent progress
Aims Despite advances in health research and digital innovation, many African countries continue to face substantial resource constraints, fragmented capacity‐building efforts and a shortage of skilled professionals in medicines development and regulatory science.
Tirhani Maluleke +7 more
wiley +1 more source
Improving service delivery in the public sector through strategic cost management: the case of a public private partnership in South Africa [PDF]
Includes abstract.Includes bibliographical references.The key objective involved the research to discover how strategic cost management may improve service delivery.
Arendse, Kevin Brian
core
Public-private partnership as an effective mechanism of interaction between government and business
The article discusses the development of public-private partnership. It is an important form of interaction between public authorities and the private sector of the economy.
S. A. Kvitka
doaj
Private opportunity, public benefit? [PDF]
The newly elected Labour government has pledged to ‘reinvigorate the Private Finance Initiative’, as part of the new emphasis on ‘public/private partnerships’ in the delivery of core public services.
John Hall
core

